NASDAQ:CDLX - Cardlytics Stock Price, Forecast & News

Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."

Cardlytics Inc (NASDAQ:CDLX) posted its quarterly earnings results on Tuesday, November, 12th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.31. The business earned $56.42 million during the quarter, compared to the consensus estimate of $50.02 million. Cardlytics had a negative net margin of 17.01% and a negative return on equity of 44.53%. Cardlytics's revenue was up 63.2% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.15) EPS. View Cardlytics' Earnings History.

Cardlytics is scheduled to release their next quarterly earnings announcement on Tuesday, March 3rd 2020. View Earnings Estimates for Cardlytics.

Cardlytics will be holding an earnings conference call on Tuesday, March 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Cardlytics issued an update on its fourth quarter 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $68.5-69.5 million, compared to the consensus revenue estimate of $59 million.

7 Wall Street analysts have issued 1-year target prices for Cardlytics' shares. Their forecasts range from $26.00 to $100.00. On average, they anticipate Cardlytics' stock price to reach $62.00 in the next year. This suggests that the stock has a possible downside of 37.3%. View Analyst Price Targets for Cardlytics.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cardlytics.

News stories about CDLX stock have trended somewhat positive on Friday, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cardlytics earned a media sentiment score of 1.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for Cardlytics.

Some companies that are related to Cardlytics include 58.com (WUBA), Stars Group (TSG), InterXion (INXN), GDS (GDS), Wix.Com (WIX), Sabre (SABR), HUYA (HUYA), Switch (SWCH), Tripadvisor (TRIP), Medallia (MDLA), Pluralsight (PS), SVMK (SVMK), DouYu International (DOYU), Livongo Health (LVGO) and Eventbrite (EB).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include Caterpillar (CAT), Alibaba Group (BABA), Advanced Micro Devices (AMD), NVIDIA (NVDA), Trade Desk (TTD), Shopify (SHOP), Verizon Communications (VZ), AbbVie (ABBV), Paycom Software (PAYC) and Range Resources (RRC).

(CDLX) raised $76 million in an initial public offering (IPO) on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Cardlytics' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include FMR LLC (16.89%), CAS Investment Partners LLC (12.36%), Jennison Associates LLC (2.11%), Bank of New York Mellon Corp (1.93%), Bank of America Corp DE (1.69%) and Renaissance Technologies LLC (1.65%). Company insiders that own Cardlytics stock include Aimia Inc, Bryce Youngren, Clifford Sosin, David Leslie Adams, David Thomas Evans, Kirk Somers, Lynne Marie Laube, Mark A Johnson, Polaris Venture Management Co, Scott D Grimes and Tony Weisman. View Institutional Ownership Trends for Cardlytics.

CDLX stock was sold by a variety of institutional investors in the last quarter, including Polaris Venture Management Co. V L.L.C., Jennison Associates LLC, UBS Oconnor LLC, Penn Capital Management Co. Inc., Nicholas Investment Partners LP, New York State Common Retirement Fund, Goldman Sachs Group Inc. and PNC Financial Services Group Inc.. Company insiders that have sold Cardlytics company stock in the last year include Aimia Inc, Bryce Youngren, David Leslie Adams, David Thomas Evans, Kirk Somers, Lynne Marie Laube, Mark A Johnson, Polaris Venture Management Co, Scott D Grimes and Tony Weisman. View Insider Buying and Selling for Cardlytics.

CDLX stock was purchased by a variety of institutional investors in the last quarter, including CAS Investment Partners LLC, Bank of New York Mellon Corp, Victory Capital Management Inc., Renaissance Technologies LLC, Lord Abbett & CO. LLC, Victory Capital Management Inc., FMR LLC and Crawford Lake Capital Management LLC. View Insider Buying and Selling for Cardlytics.

Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CDLX stock can currently be purchased for approximately $98.88.

Cardlytics has a market capitalization of $2.26 billion and generates $150.68 million in revenue each year. The company earns $-53,040,000.00 in net income (profit) each year or ($2.14) on an earnings per share basis. View Additional Information About Cardlytics.

The official website for Cardlytics is http://www.cardlytics.com/.

Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected]